What is the actual effect of my country's new crown vaccine?Can the elderly with chronic disease be vaccinated?Latest response!

The State Council's joint prevention and control mechanism held a press conference on July 23 to introduce the relevant situation of the safety effectiveness of the vaccine vaccine of the new crown virus. What is the vaccine vaccination? What is the actual effect of the vaccine? Come and follow- together-

What is the current new crown vaccination in my country?

The new crown vaccination has increased significantly in all ages. As of July 22, 31 provinces (cities, districts) and Xinjiang Production and Construction Corps have reported a total of 341.6727 million doses of new crown vaccines. The full vaccination was 126.4901 million, and the vaccination rate reached 89.7%; the reinforcement of 797.985 million people was completed, and the immune vaccination rate was 71.7%. In general, the vaccination rate is relatively high.

my country's current party and state leaders have completed the new crown vaccine vaccination

my country's current party and state leaders have completed the vaccination of the new crown vaccine, and they are all domestic vaccines. This situation fully shows the high attention of my country's leaders' attention to the prevention and control of the new crown epidemic, and has a high trust in the new crown vaccine produced in my country.

At present, three new crown vaccines in my country have been included in the emergency use list by the World Health Organization, and more than 100 countries have approved the use of vaccines produced in my country. Many of them use Chinese vaccines as the only vaccine used by young children.

Including more than 30 countries including Turkey, Serbia, Cambodia, the Philippines, the United Arab Emirates, Saudi Arabia, Jordan, Indonesia, Peru, Chile, etc., they took the lead in vaccination with Chinese vaccines. These situations fully show that my country's vaccine has been widely recognized by the international community.

What is the new crown vaccination of the elderly?

At present, at least 1 dose of vaccination rates over 60 years of age in my country is 89.6%, the basic immunization vaccination ratio reaches 84.7%, and the immunization vaccination rate has reached 67.3%.

Judging from these data, the coverage of vaccination over 60 years old and over 60 years of age has improved. However, there is still room for improvement, mainly two issues: one is that the vaccination coverage rate over 80 years of age over 80s needs to be improved; the other is that the enhanced vaccination rate of the elderly needs to be improved.

Is the elderly with chronic diseases suitable for vaccination?

From the current situation of vaccination at home and abroad, chronic diseases are not contraindications for vaccination of new crown virus vaccines. Including tumors, hypertension, diabetes, chronic pulmonary blockers, etc., as long as the health status is stable, the drug control is good, and it is not used as a taboo for vaccination as a new coronary virus vaccine.

There are several cases of suggestions as vaccination taboos:

First, severe allergic reactions occur during vaccination, such as allergic shock and throat edema.

The second is because various diseases are in the fever stage, such as influenza, pneumonia or other diseases.

Third, some chronic diseases have acute attacks. For example, tumor patients are doing chemotherapy, hypertension patients have high blood pressure, and some nervous system diseases are onset.

Fourth, all kinds of severe diseases have entered the end.

What is the actual effect of my country's vaccine?

The effect of new crown vaccines is very significant on prevention of disease prevention, severe illness, and death prevention, and strengthening immunity can further improve the protection effect. Studies have found that infected people aged 18 to 59 who have been vaccinated and strengthened throughout the process, the risk of developing from light to ordinary types is 63%and 65%lower than those who have not vaccinated vaccines, respectively. The risks developed into severe illnesses were 91%and 94%lower. For those who are infected with a full vaccination and enhanced inoculation, the risk of developing from light to ordinary types is 73%and 82%lower than those who have not vaccinated vaccines. The risk of developing from ordinary and below general types to severe diseases is more risks. Infected people who did not vaccine were 89%and 95%lower. Our country's vaccine complies with the standards of the World Health Organization for the new crown vaccine, which is to prevent diseases, prevent severe illnesses, and prevent death.

After the human body is vaccinated, the immune response between different individuals is different. From the perspective of the virus, it has continuously mutated itself, and the immune protection capacity produced after vaccination is not exactly the same. Among the people who have vaccinated the new crown vaccine, even if a breakthrough infection occurs, the risk of severe illnesses and deaths is greatly reduced.

Wearing masks, vaccine enhanced needles and other protective measures can achieve better prevention results. This is why we have requested the vaccine to strengthen personal protection.

Is the existing vaccine valid for the Omikon mutant strain?

The results of many studies show that the effects of existing vaccines at home and abroad still maintain a high level. my country's vaccine still has a good protective effect on the severe disease and death caused by the mutant strains of Omikon, and strengthening immunity can further reduce the risk of hospitalization, severe and death.

The R & D work of Omikon's Vaccination is steadily promoted. As long as there is a need, in accordance with relevant regulations, it can quickly start emergency use approval procedures and provide vaccination.

How to ensure the quality and safety of the vaccine?

First of all, before the factory is issued, enterprises must be inspected in accordance with the national approval standards. The inspection items include physical indicators, chemical indicators, identification indicators, validity indicators, and safety indicators.

Secondly, the national legal inspection agencies need to be approved to issue the vaccine. In the process, they are inspected in accordance with national approval standards. The inspection report is issued after the inspection is qualified to meet the standard, allowing release. After the new crown vaccine was listed, the national legal institutions transferred the provinces to the provinces, expanded the ability to supplement the approval and enhance the ability to issue issuance. At the same time, the pharmaceutical supervision institution also dispatched a inspector in the factory to the vaccine manufacturer to check the entire process of vaccine production to ensure that the production process meets the requirements of national regulations.

In addition, after the vaccine finished product was released, there was a series of measures to ensure the quality of the vaccine during use. For example, the production line expansion work process and technical guidelines have been introduced, and an independent operation of the new crown vaccine information traceability regulatory system is established to ensure that each vaccine source can be chased and the direction can be checked.

What is the difference between homologous strengthening immunity and order to strengthen immunity?

Regardless of the use of homologous enhanced vaccination, that is, the strengthening of the same technical route vaccine, or the sequential enhancement, that is, the vaccine of different technical routes can be strengthened, which can greatly improve the protection effect. The effect is more obvious. Therefore, it is necessary to strengthen the needle.

Why do children's vaccines use the same dosage as adults?

Our country's 3-17-year-old minor adopts the same dose as adults, which are determined according to the data of clinical trials. In history, there are various vaccines, including the activated spinal ashginitis vaccine, rabies vaccine, hepatitis A and other vaccines. They are consistent with the results of clinical research and adult doses. It is safe and effective that children's use of the same dose as adults.

The MRNA vaccine of two foreign companies uses 30 micrograms and 100 micrograms. Children use one -third of the adult dose. It is mainly based on its own characteristics of the vaccine. choose. Different technical routes produced by the production of immune response in the body due to different components, so there is no comparability in terms of dosage.

- END -